478
Views
9
CrossRef citations to date
0
Altmetric
Special Focus Review

Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C

, &
Pages 1569-1576 | Received 24 Jan 2013, Accepted 17 Apr 2013, Published online: 31 May 2013

Figures & data

Figure 1. Increases in both the number and function of Treg cells have been implicated in the pathogenesis of chronic hepatitis C. Virus-associated regulatory T cell epitopes, homologous to peptide sequences found in the human plasma proteome, induce nTreg cell activation, conversion of Teff to iTreg cells and infectious tolerance (A). Viral epitopes lacking human homology, which are presented by immature DCs, elicit additional HCV-specific iTreg cells (B). Treg cells inhibit Teff cell function by direct, contact-dependent and -independent mechanisms and by indirect mechanisms that affect DC maturation and/or immunostimulatory activity (C).

Figure 1. Increases in both the number and function of Treg cells have been implicated in the pathogenesis of chronic hepatitis C. Virus-associated regulatory T cell epitopes, homologous to peptide sequences found in the human plasma proteome, induce nTreg cell activation, conversion of Teff to iTreg cells and infectious tolerance (A). Viral epitopes lacking human homology, which are presented by immature DCs, elicit additional HCV-specific iTreg cells (B). Treg cells inhibit Teff cell function by direct, contact-dependent and -independent mechanisms and by indirect mechanisms that affect DC maturation and/or immunostimulatory activity (C).

Figure 2. Contrasting contributions of Treg cells to the pathogenesis of chronic hepatitis C. An increased ratio of Treg to Teff cells impairs spontaneous viral clearance and suppresses liver injury and the pathogenesis of chronic hepatitis C as the disease progresses.

Figure 2. Contrasting contributions of Treg cells to the pathogenesis of chronic hepatitis C. An increased ratio of Treg to Teff cells impairs spontaneous viral clearance and suppresses liver injury and the pathogenesis of chronic hepatitis C as the disease progresses.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.